InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Kanes Stephen, Directeur médical. Officer active across 2 companies, notably Sage Therapeutics, Inc.. Aggregated, 5 filings have been logged. Activity tracked since 15 June 2021. The latest transaction was disclosed on 19 October 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations5 total
120,000 sharesOrdinary SharesSEC:0001470831-26-000617:0
3,800 shares0Common StockSEC:0001562180-21-006596
3,800 shares0Common StockSEC:0001562180-21-006596:0
3,500 shares0Common StockSEC:0001562180-21-004338
3,500 shares0Common StockSEC:0001562180-21-004338:0
5 of 5 declarations
About Kanes Stephen
Stephen Kanes serves as the Chief Medical Officer at Sage Therapeutics, Inc. He is responsible for leading the company's clinical and research initiatives, ensuring alignment of medical objectives with overall strategy. His expertise in the pharmaceutical field contributes to the advancement of innovative treatments.
